Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (37)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by De Mas, P.
Right arrow Articles by Bujan, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Mas, P.
Right arrow Articles by Bujan, L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 16, No. 6, 1204-1208, June 2001
© 2001 European Society of Human Reproduction and Embryology

Increased aneuploidy in spermatozoa from testicular tumour patients after chemotherapy with cisplatin, etoposide and bleomycin

Philippe De Mas2, Myriam Daudin1, Marie-Claire Vincent2, Georges Bourrouillou1,2, Patrick Calvas2, Roger Mieusset1 and Louis Bujan1,3

1 Human Fertility Research Group and CECOS Midi-Pyrénées, Centre de Stérilité Masculine, Service d'Uro-Andrologie, Hôpital La Grave and 2 Service de Génétique Médicale, Hôpital Purpan, Toulouse, France

Testicular cancer is the most common neoplasia occurring in the young male population. The PEB (cisplatin, etoposide and bleomycin) adjuvant chemotherapy usually proposed after orchidectomy in non seminomatous tumours, and in metastatic seminomas, has improved the long-term survival of these patients. Following an azoospermic period, sperm cell recovery is generally observed after treatment delivery, but little is known about the genetic consequences on these new spermatozoa. To estimate the chromosomal consequences of this chemotherapy on sperm cells during the period of recovery of spermatogenesis, sperm cell aneuploidy was studied in testicular cancer patients, at 6–18 months after PEB adjuvant chemotherapy delivery, using fluorescence in-situ hybridization (FISH) of chromosomes 7, 16, 18, X and Y with specific DNA probes. A significant increase in the frequency of diploidy and disomy for chromosomes 16, 18 and XY was observed in treated patients compared with a healthy control group. Spermatozoa aneuploidy occurring during the spermatogenesis recovery period might be a possible side effect of the PEB regimen. Thus, practitioners should be advised to provide counselling about the need for an appropriate duration of contraception. Moreover, genetic counselling should be offered in cases of pregnancy occurring soon after the end of chemotherapy.

Key words: chemotherapy/FISH /PEB side effects/sperm aneuploidy/testicular cancer

3 To whom correspondence should be addressed at: Human Fertility Research Group and CECOS Midi-Pyrénées, Hôpital La Grave, 31052 Toulouse, France. E-mail: bujan{at}cict.fr


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol Hum ReprodHome page
R. J. Ortiz, C. Lizama, V. A. Codelia, and R. D. Moreno
A molecular evaluation of germ cell death induced by etoposide in pubertal rat testes
Mol. Hum. Reprod., June 1, 2009; 15(6): 363 - 371.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. Vozdova, E. Oracova, V. Horinova, and J. Rubes
Sperm fluorescence in situ hybridization study of meiotic segregation and an interchromosomal effect in carriers of t(11;18)
Hum. Reprod., March 1, 2008; 23(3): 581 - 588.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
H.G. Tempest, E. Ko, P. Chan, B. Robaire, A. Rademaker, and R.H. Martin
Sperm aneuploidy frequencies analysed before and after chemotherapy in testicular cancer and Hodgkin's lymphoma patients
Hum. Reprod., February 1, 2008; 23(2): 251 - 258.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
G. Delbes, B. F. Hales, and B. Robaire
Effects of the Chemotherapy Cocktail Used to Treat Testicular Cancer on Sperm Chromatin Integrity
J Androl, March 1, 2007; 28(2): 241 - 249.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
H. Chemes
Editorial Commentary
J Androl, March 1, 2007; 28(2): 250 - 251.
[Full Text] [PDF]


Home page
Hum ReprodHome page
O. Stahl, J. Eberhard, K. Jepson, M. Spano, M. Cwikiel, E. Cavallin-Stahl, and A. Giwercman
Sperm DNA integrity in testicular cancer patients
Hum. Reprod., December 1, 2006; 21(12): 3199 - 3205.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
L. Gandini, P. Sgro, F. Lombardo, D. Paoli, F. Culasso, L. Toselli, P. Tsamatropoulos, and A. Lenzi
Effect of chemo- or radiotherapy on sperm parameters of testicular cancer patients
Hum. Reprod., November 1, 2006; 21(11): 2882 - 2889.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
F. Marchetti, F. S. Pearson, J. B. Bishop, and A. J. Wyrobek
Etoposide induces chromosomal abnormalities in mouse spermatocytes and stem cell spermatogonia
Hum. Reprod., April 1, 2006; 21(4): 888 - 895.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
A. M. Bieber, L. Marcon, B. F. Hales, and B. Robaire
Effects of Chemotherapeutic Agents for Testicular Cancer on the Male Rat Reproductive System, Spermatozoa, and Fertility
J Androl, March 1, 2006; 27(2): 189 - 200.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
Y. Xia, S. Cheng, Q. Bian, L. Xu, M. D. Collins, H. C. Chang, L. Song, J. Liu, S. Wang, and X. Wang
Genotoxic Effects on Spermatozoa of Carbaryl-Exposed Workers
Toxicol. Sci., May 1, 2005; 85(1): 615 - 623.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
G. Bahadur, O. Ozturk, A. Muneer, R. Wafa, A. Ashraf, N. Jaman, S. Patel, A.W. Oyede, and D.J. Ralph
Semen quality before and after gonadotoxic treatment
Hum. Reprod., March 1, 2005; 20(3): 774 - 781.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
B. F. Hales, T. S. Barton, and B. Robaire
Impact of Paternal Exposure to Chemotherapy on Offspring in the Rat
J Natl Cancer Inst Monographs, March 1, 2005; 2005(34): 28 - 31.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
A. J. Wyrobek, T. E. Schmid, and F. Marchetti
Relative Susceptibilities of Male Germ Cells to Genetic Defects Induced by Cancer Chemotherapies
J Natl Cancer Inst Monographs, March 1, 2005; 2005(34): 31 - 35.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
D. Shin, K. C. Lo, and L. I. Lipshultz
Treatment Options for the Infertile Male With Cancer
J Natl Cancer Inst Monographs, March 1, 2005; 2005(34): 48 - 50.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
T. S. Barton, A. J. Wyrobek, F. S. Hill, B. Robaire, and B. F. Hales
Numerical Chromosomal Abnormalities in Rat Epididymal Spermatozoa Following Chronic Cyclophosphamide Exposure
Biol Reprod, October 1, 2003; 69(4): 1150 - 1157.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. Meseguer, N. Garrido, J. Remohi, A. Pellicer, C. Simon, J. M. Martinez-Jabaloyas, and M. Gil-Salom
Testicular sperm extraction (TESE) and ICSI in patients with permanent azoospermia after chemotherapy
Hum. Reprod., June 1, 2003; 18(6): 1281 - 1285.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
B. Eskenazi, A.J. Wyrobek, S.A. Kidd, X. Lowe, D. Moore II, K. Weisiger, and M. Aylstock
Sperm aneuploidy in fathers of children with paternally and maternally inherited Klinefelter syndrome
Hum. Reprod., March 1, 2002; 17(3): 576 - 583.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.